Identification of gene expression profiles associated with cortisol secretion in adrenocortical adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 6, 2013, Pages

  Roussel, Hortense Wilmot ^a,b   Vezzosi, Delphine ^a,b,c   Rizk Rabin, Marthe ^a,b   Barreau, Olivia ^a,b   Ragazzon, Bruno ^a,b   René Corail, Fernande ^a,b   De Reynies, Aurélien ^d   Bertherat, Jérôme ^a,b   Assié, Guillaume ^a,b  

^a Hôpital Cochin ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SERVICE DE PNEUMOLOGIE   (France)

^d Plateforme de Bioinformatique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTATHIONE TRANSFERASE; HYDROCORTISONE; PHOSPHODIESTERASE; PHOSPHODIESTERASE VIIIB; TRANSCRIPTION FACTOR GATA 6; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ARTICLE; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE SURGERY; ENZYME ACTIVITY; ENZYME INACTIVATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; HYDROCORTISONE RELEASE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; WESTERN BLOTTING;

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; AGED; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; TRANSCRIPTOME;

EID: 84878510580     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4237     Document Type: Article

References (40)

1. Kramer RE, Rainey WE, Funkenstein B, Dee A, Simpson ER, Waterman MR. Induction of synthesis of mitochondrial steroidogenic enzymes of bovine adrenocortical cells by analogs of cyclic AMP. J Biol Chem. 1984;259:707-713. (Pubitemid 14192131)
2. Vezzosi D, Bertherat J, Groussin L. Pathogenesis of benign adrenocortical tumors. Best Pract Res Clin Endocrinol Metab. 2010;24:893-905.
3. Choi M, Scholl UI, Yue P, et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768-772.
4. Bassett MH, Mayhew B, Rehman K, et al. Expression profiles for steroidogenic enzymes in adrenocortical disease. J Clin Endocrinol Metab. 2005;90:5446-5455. (Pubitemid 41262314)
5. Suzuki H, Shibata H, Maruyama T, Ishimura Y, Saruta T. Significance of steroidogenic enzymes in the pathogenesis of hyperfunctioning and non-hyperfunctioning adrenal tumor. Steroids. 1995;60:42-47.
6. De Reynies A, Assie G, Rickman DS, et al. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol. 2009;27:1108-1115.
7. Vincent-Dejean C, Cazabat L, Groussin L, et al. Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity. Eur J Endocrinol. 2008;158:829-839. (Pubitemid 351837372)
8. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria; 2012.
9. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15.
10. Hanukoglu I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab Rev. 2006;38:171-196. (Pubitemid 43739006)
11. Reincke M, Beuschlein F, Lalli E, et al. DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis. J Clin Endocrinol Metab. 1998;83:2597-2600. (Pubitemid 28503071)
12. Bourdeau I, Antonini SR, Lacroix A, et al. Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene. 2004;23:1575-1585. (Pubitemid 38406520)
13. Assie G, Giordano TJ, Bertherat J. Gene expression profiling in adrenocortical neoplasia. Mol Cell Endocrinol. 2012;351:111-117.
14. Cherradi N, Brandenburger Y, Capponi AM. Mitochondrial regulation of mineralocorticoid biosynthesis by calcium and the StAR protein. Eur J Endocrinol. 1998;139:249-256. (Pubitemid 28430532)
15. Streuli C. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol. 1999;11:634-640. (Pubitemid 29460407)
16. Crickard K, IL CR, Jaffe RB. Control of proliferation of human fetal adrenal cells in vitro. J Clin Endocrinol Metab. 1981;53:790-796. (Pubitemid 13238660)
17. Chamoux E, Narcy A, Lehoux JG, Gallo-Payet N. Fibronectin, laminin, and collagen IV interact with ACTH and angiotensin II to dictate specific cell behavior and secretion in human fetal adrenal cells in culture. Endocr Res. 2002;28:637-640. (Pubitemid 36042529)
18. Enberg U, Farnebo LO, Wedell A, et al. In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17. World J Surg. 2001;25:957-966. (Pubitemid 32666399)
19. Ogo A, Haji M, Ohashi M, Nawata H. Markedly increased expression of cytochrome P-450 17α-hydroxylase (P-450c17) mRNA in adrenocortical adenomas from patients with Cushing's syndrome. Mol Cell Endocrinol. 1991;80:83-89.
20. Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal. 2004;6:289-300. (Pubitemid 38332586)
21. 2-dependent, reversible inactivation of peroxiredoxin III in mitochondria. Mol Cell. 2012;46:584-594.
22. Stark T, Mankowitz L, Depierre JW. Expression of glutathione transferase isoenzymes in the human H295R adrenal cell line and the effect of forskolin. J Biochem Mol Toxicol. 2002;16:169-173. (Pubitemid 35153695)
23. Kiiveri S, Liu J, Westerholm-Ormio M, et al. Differential expression of GATA-4 and GATA-6 in fetal and adult mouse and human adrenal tissue. Endocrinology. 2002;143:3136-3143. (Pubitemid 34809886)
24. Parviainen H, Kiiveri S, Bielinska M, et al. GATA transcription factors in adrenal development and tumors. Mol Cell Endocrinol 2007;265-266:17-22. (Pubitemid 46273979)
25. Jimenez P, Saner K, Mayhew B, Rainey WE. GATA-6 is expressed in the human adrenal and regulates transcription of genes required for adrenal androgen biosynthesis. Endocrinology. 2003;144:4285-4288. (Pubitemid 37204826)
26. Barbosa AS, Giacaglia LR, Martin RM, Mendonca BB, Lin CJ. Assessment of the role of transcript for GATA-4 as a marker of unfavorable outcome in human adrenocortical neoplasms. BMC Endocr Disord. 2004;4:3.
27. Kiiveri S, Siltanen S, Rahman N, et al. Reciprocal changes in the expression of transcription factors GATA-4 and GATA-6 accompany adrenocortical tumorigenesis in mice and humans. Mol Med. 1999;5:490-501. (Pubitemid 29399754)
28. Kempna P, Fluck CE. Adrenal gland development and defects. Best Pract Res Clin Endocrinol Metab. 2008;22:77-93. (Pubitemid 351218272)
29. Shibata H, Ikeda Y, Mukai T, et al. Expression profiles of COUP-TF, DAX-1, and SF-1 in the human adrenal gland and adrenocortical tumors: possible implications in steroidogenesis. Mol Genet Metab. 2001;74:206-216. (Pubitemid 32955161)
30. Shibata H, Kurihara I, Kobayashi S, et al. Regulation of differential COUP-TF-coregulator interactions in adrenal cortical steroidogenesis. J Steroid Biochem Mol Biol. 2003;85:449-456. (Pubitemid 37011121)
31. Kelly SN, Mckenna TJ, Young LS. Modulation of steroidogenic enzymes by orphan nuclear transcriptional regulation may control diverse production of cortisol and androgens in the human adrenal. J Endocrinol. 2004;181:355-365.
32. Lu L, Suzuki T, Yoshikawa Y, et al. Nur-related factor 1 and nerve growth factor-induced clone B in human adrenal cortex and its disorders. J Clin Endocrinol Metab. 2004;89:4113-4118. (Pubitemid 39071520)
33. Almeida MQ, Stratakis CA. How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues? Mol Cell Endocrinol. 2011;336:162-168.
34. Chida D, Nakagawa S, Nagai S, et al. Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc Natl Acad Sci USA. 2007;104:18205-18210. (Pubitemid 350210845)
35. Assie G, Louiset E, Sturm N, et al. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome. J Clin Endocrinol Metab. 2010;95:E253-E262.
36. Dorn GW 2nd, Oswald KJ, McCluskey TS, Kuhel DG, Liggett SB. α2A-Adrenergic receptor stimulated calcium release is transduced by Gi-associated G(βγ)-mediated activation of phospholipase C. Biochemistry. 1997;36:6415-6423. (Pubitemid 27231399)
37. Tsai LC, Shimizu-Albergine M, Beavo JA. The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland. Mol Pharmacol. 2011;79:639-648.
38. Horvath A, Mericq V, Stratakis CA. Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N Engl J Med. 2008;358:750-752. (Pubitemid 351240774)
39. Yu B, Ragazzon B, Rizk-Rabin M, Bertherat J. Protein kinase a alterations in endocrine tumors. Horm Metab Res. 2012;44:741-748.
40. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:3.